{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T09:26:59Z","timestamp":1681118819860},"reference-count":22,"publisher":"Japanese Association of Virology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Uirusu"],"published-print":{"date-parts":[[2015]]},"DOI":"10.2222\/jsv.65.61","type":"journal-article","created":{"date-parts":[[2016,2,26]],"date-time":"2016-02-26T22:25:19Z","timestamp":1456525519000},"page":"61-70","source":"Crossref","is-referenced-by-count":3,"title":["Ebola vaccine and treatment"],"prefix":"10.2222","volume":"65","author":[{"given":"Ayato","family":"TAKADA","sequence":"first","affiliation":[{"name":"Hokkaido University Research Center for Zoonosis Control"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1062","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Bukreyev AA, Chandran K, Dolnik O, Dye JM, Ebihara H, Leroy EM, Muhlberger E, Netesov SV, Patterson JL, Paweska JT, Saphire EO, Smither SJ, Takada A, Towner JS, Volchkov VE, Warren TK, Kuhn JH. Discussions and decisions of the 2012-2014 International Committee on Taxonomy of Viruses (ICTV) Filoviridae Study Group, January 2012-June 2013. Arch Virol 159:821-830, 2014.","DOI":"10.1007\/s00705-013-1846-9"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Negredo A, Palacios G, Vcitation=33) Ccitation=53) Takada A, Ebihara H, Feldmann H, Geisbert TW, Kawaoka Y. Epitopes required for antibody-dependent enhancement of Ebola virus infection. J Infect Dis 196 Suppl 2:S347-356, 2007.","DOI":"10.1086\/520581"},{"key":"3","doi-asserted-by":"crossref","unstructured":"54) Nakayama E, Yokoyama A, Miyamoto H, Igarashi M, Kishida N, Matsuno K, Marzi A, Feldmann H, Ito K, Saijo M, Takada A. Enzyme-linked immunosorbent assay for detection of filovirus species-specific antibodies. Clin Vaccine Immunol 17:1723-1728, 2010.","DOI":"10.1128\/CVI.00170-10"},{"key":"4","doi-asserted-by":"crossref","unstructured":"55) Geisbert TW, Daddario-DiCaprio KM, Geisbert JB, Young HA, Formenty P, Fritz EA, Larsen T, Hensley LE. Marburg virus Angola infection of rhesus macaques: pathogenesis and treatment with recombinant nematode anticoagulant protein c2. J Infect Dis 196 Suppl 2:S372-381, 2007.","DOI":"10.1086\/520608"},{"key":"5","doi-asserted-by":"crossref","unstructured":"56) Geisbert TW, Hensley LE, Jahrling PB, Larsen T, Geisbert JB, Paragas J, Young HA, Fredeking TM, Rote WE, Vlasuk GP. Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa\/tissue factor: a study in rhesus monkeys. Lancet 362:1953-1958, 2003.","DOI":"10.1016\/S0140-6736(03)15012-X"},{"key":"6","doi-asserted-by":"crossref","unstructured":"57) Hensley LE, Stevens EL, Yan SB, Geisbert JB, Macias WL, Larsen T, Daddario-DiCaprio KM, Cassell GH, Jahrling PB, Geisbert TW. Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever. J Infect Dis 196 Suppl 2:S390-399, 2007.","DOI":"10.1086\/520598"},{"key":"7","doi-asserted-by":"crossref","unstructured":"58) Matsuno K, Takada A. Antibody Therapy as a future treatment option for Ebola virus infection. Future Virol 2:607-614, 2007.","DOI":"10.2217\/17460794.2.6.607"},{"key":"8","doi-asserted-by":"crossref","unstructured":"59) Oswald WB, Geisbert TW, Davis KJ, Geisbert JB, Sullivan NJ, Jahrling PB, Parren PW, Burton DR. Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys. PLoS Pathog 3:e9, 2007.","DOI":"10.1371\/journal.ppat.0030009"},{"key":"9","doi-asserted-by":"crossref","unstructured":"60) Dye JM, Herbert AS, Kuehne AI, Barth JF, Muhammad MA, Zak SE, Ortiz RA, Prugar LI, Pratt WD. Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease. Proc Natl Acad Sci USA 109:5034-5039, 2012.","DOI":"10.1073\/pnas.1200409109"},{"key":"10","doi-asserted-by":"crossref","unstructured":"61) Marzi A, Yoshida R, Miyamoto H, Ishijima M, Suzuki Y, Higuchi M, Matsuyama Y, Igarashi M, Nakayama E, Kuroda M, Saijo M, Feldmann F, Brining D, Feldmann H, Takada A. Protective efficacy of neutralizing monoclonal antibodies in a nonhuman primate model of Ebola hemorrhagic fever. PLoS One 7:e36192, 2012.","DOI":"10.1371\/journal.pone.0036192"},{"key":"11","doi-asserted-by":"crossref","unstructured":"62) Qiu X, Audet J, Wong G, Pillet S, Bello A, Cabral T, Strong JE, Plummer F, Corbett CR, Alimonti JB, Kobinger GP. Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies. Sci Transl Med 4:138ra81, 2012.","DOI":"10.1126\/scitranslmed.3003876"},{"key":"12","doi-asserted-by":"crossref","unstructured":"63) Olinger GG Jr, Pettitt J, Kim D, Working C, Bohorov O, Bratcher B, Hiatt E, Hume SD, Johnson AK, Morton J, Pauly M, Whaley KJ, Lear CM, Biggins JE, Scully C, Hensley L, Zeitlin L. Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques. Proc Natl Acad Sci USA109:18030-18035, 2012.","DOI":"10.1073\/pnas.1213709109"},{"key":"13","doi-asserted-by":"crossref","unstructured":"64) Qiu X, Wong G, Audet J, Bello A, Fernando L, Alimonti JB, Fausther-Bovendo H, Wei H, Aviles J, Hiatt E, Johnson A, Morton J, Swope K, Bohorov O, Bohorova N, Goodman C, Kim D, Pauly MH, Velasco J, Pettitt J, Olinger GG, Whaley K, Xu B, Strong JE, Zeitlin L, Kobinger GP. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature 514:47-53, 2014.","DOI":"10.1038\/nature13777"},{"key":"14","doi-asserted-by":"crossref","unstructured":"65) McCarthy M. US signs contract with ZMapp maker to accelerate development of the Ebola drug. BMJ 349:g5488, 2014.","DOI":"10.1136\/bmj.g5488"},{"key":"15","doi-asserted-by":"crossref","unstructured":"66) Furuta Y, Takahashi K, Kuno-Maekawa M, Sangawa H, Uehara S, Kozaki K, Nomura N, Egawa H, Shiraki K. Mechanism of action of T-705 against influenza virus. Antimicrob Agents Chemother 49:981-986, 2005.","DOI":"10.1128\/AAC.49.3.981-986.2005"},{"key":"16","doi-asserted-by":"crossref","unstructured":"67) Sangawa 1, Komeno T, Nishikawa H, Yoshida A, Takahashi K, Nomura N, Furuta Y. Mechanism of action of T-705 ribosyl triphosphate against influenza virus RNA polymerase. Antimicrob Agents Chemother 57:5202-5208, 2013.","DOI":"10.1128\/AAC.00649-13"},{"key":"17","doi-asserted-by":"crossref","unstructured":"68) Smither SJ, Eastaugh LS, Steward JA, Nelson M, Lenk RP, Lever MS. Postexposure efficacy of oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model. Antiviral Res 104:153-155, 2014.","DOI":"10.1016\/j.antiviral.2014.01.012"},{"key":"18","doi-asserted-by":"crossref","unstructured":"69) Oestereich L, Ludtke A, Wurr S, Rieger T, Munoz-Fontela C, Gunther S. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model. Antiviral Res 105:17-21, 2014.","DOI":"10.1016\/j.antiviral.2014.02.014"},{"key":"19","doi-asserted-by":"crossref","unstructured":"70) Kupferschmidt K, Cohen J. Infectious diseases. Ebola drug trials lurch ahead. Science 347:701-702, 2015.","DOI":"10.1126\/science.347.6223.701"},{"key":"20","doi-asserted-by":"crossref","unstructured":"71) Warren TK, Wells J, Panchal RG, Stuthman KS, Garza NL, Van Tongeren SA, Dong L, Retterer CJ, Eaton BP, Pegoraro G, Honnold S, Bantia S, Kotian P, Chen X, Taubenheim BR, Welch LS, Minning DM, Babu YS, Sheridan WP, Bavari S. Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430. Nature 508:402-405, 2014.","DOI":"10.1038\/nature13027"},{"key":"21","doi-asserted-by":"crossref","unstructured":"72) Geisbert TW, Lee AC, Robbins M, Geisbert JB, Honko AN, Sood V, Johnson JC, de Jong S, Tavakoli I, Judge A, Hensley LE, Maclachlan I. Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study. Lancet 375:1896-1905, 2010.","DOI":"10.1016\/S0140-6736(10)60357-1"},{"key":"22","doi-asserted-by":"crossref","unstructured":"73) Heald AE, Iversen PL, Saoud JB, Sazani P, Charleston JS, Axtelle T, Wong M, Smith WB, Vutikullird A, Kaye E. Safety and pharmacokinetic profiles of phosphorodiamidate morpholino oligomers with activity against ebola virus and marburg virus: results of two single-ascending-dose studies. Antimicrob Agents Chemother 58:6639-6647, 2014.","DOI":"10.1128\/AAC.03442-14"}],"container-title":["Uirusu"],"original-title":["\u30a8\u30dc\u30e9\u30a6\u30a4\u30eb\u30b9\u306b\u5bfe\u3059\u308b\u30ef\u30af\u30c1\u30f3\u304a\u3088\u3073\u6cbb\u7642\u6cd5"],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsv\/65\/1\/65_61\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T01:49:00Z","timestamp":1567648140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsv\/65\/1\/65_61\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2222\/jsv.65.61","relation":{},"ISSN":["0042-6857","1884-3433"],"issn-type":[{"value":"0042-6857","type":"print"},{"value":"1884-3433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}